| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell junction organization | CTTNBP2 ABL2 MYOT ANK2 GRIA1 CHD4 PTPRT CDH24 PTPN13 DST IQSEC1 DNM3 TLN2 FGFR2 BSN CDH9 PDZRN3 | 6.25e-06 | 974 | 103 | 17 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse organization | CTTNBP2 ABL2 MYOT GRIA1 CHD4 PTPRT PTPN13 IQSEC1 DNM3 TLN2 FGFR2 BSN CDH9 PDZRN3 | 7.81e-06 | 685 | 103 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell division | STX2 MAP9 DR1 WAPL MIS18BP1 TTC28 USP37 NEDD1 LATS1 TPX2 FGFR2 PAX6 TRIM36 SON | 9.50e-06 | 697 | 103 | 14 | GO:0051301 |
| Domain | - | MYOT VTCN1 IGSF5 VSIG10 LEPR PTPRT IFNAR1 SIGLEC1 FGFR2 KIR2DL1 KIR2DL2 TRIM36 | 3.47e-04 | 663 | 105 | 12 | 2.60.40.10 |
| Domain | IG_LIKE | MYOT VTCN1 IGSF5 VSIG10 LEPR PTPRT SIGLEC1 FGFR2 KIR2DL1 KIR2DL2 | 4.46e-04 | 491 | 105 | 10 | PS50835 |
| Domain | Ig-like_dom | MYOT VTCN1 IGSF5 VSIG10 LEPR PTPRT SIGLEC1 FGFR2 KIR2DL1 KIR2DL2 | 5.38e-04 | 503 | 105 | 10 | IPR007110 |
| Domain | Ig-like_fold | MYOT VTCN1 IGSF5 VSIG10 LEPR PTPRT IFNAR1 SIGLEC1 FGFR2 KIR2DL1 KIR2DL2 TRIM36 | 6.07e-04 | 706 | 105 | 12 | IPR013783 |
| Domain | IG | 6.15e-04 | 421 | 105 | 9 | SM00409 | |
| Domain | Ig_sub | 6.15e-04 | 421 | 105 | 9 | IPR003599 | |
| Domain | ZF_A20 | 6.45e-04 | 7 | 105 | 2 | PS51036 | |
| Domain | zf-A20 | 6.45e-04 | 7 | 105 | 2 | PF01754 | |
| Domain | Znf_A20 | 6.45e-04 | 7 | 105 | 2 | IPR002653 | |
| Domain | ZnF_A20 | 6.45e-04 | 7 | 105 | 2 | SM00259 | |
| Domain | PTPc | 1.08e-03 | 36 | 105 | 3 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.36e-03 | 39 | 105 | 3 | PS50055 | |
| Domain | PTPase_domain | 1.58e-03 | 41 | 105 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 1.58e-03 | 41 | 105 | 3 | PF00102 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.36e-03 | 99 | 105 | 4 | IPR029021 | |
| Domain | Znf_RING | 2.45e-03 | 326 | 105 | 7 | IPR001841 | |
| Domain | Znf_C3HC4_RING-type | 2.88e-03 | 172 | 105 | 5 | IPR018957 | |
| Domain | - | 3.83e-03 | 449 | 105 | 8 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 4.37e-03 | 459 | 105 | 8 | IPR013083 | |
| Domain | Ig_I-set | 4.39e-03 | 190 | 105 | 5 | IPR013098 | |
| Domain | I-set | 4.39e-03 | 190 | 105 | 5 | PF07679 | |
| Domain | PTPc_motif | 4.47e-03 | 59 | 105 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 4.47e-03 | 59 | 105 | 3 | IPR003595 | |
| Pubmed | CACNA2D1 CTTNBP2 LRCH2 ANK2 ZNF618 DVL2 NSD1 ZMYM2 GRIA1 CHD4 DST UBR5 IQSEC1 DNM3 TLN2 RABGEF1 TAF15 BSN GOLGB1 | 1.38e-10 | 963 | 108 | 19 | 28671696 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ABCF1 WAPL ANK2 RANBP3 GPATCH1 PARG DVL2 ZMYM2 CHD4 NEDD1 PTPN12 PTPN13 DST TPX2 TAF15 GCN1 GOLGB1 SON | 6.47e-10 | 934 | 108 | 18 | 33916271 |
| Pubmed | MIS18BP1 TTC28 RBM33 DVL2 NEDD1 ARID1A JMJD1C PTPN13 GCN1 VPS13B GOLGB1 | 6.78e-10 | 263 | 108 | 11 | 34702444 | |
| Pubmed | NOL4 IL16 WAPL TTC28 ZNF618 FAT3 BCL7B DVL2 CHD4 ARID1A HOXA9 GTPBP2 BRDT UBR5 IQSEC1 SIGLEC1 TOPORS PDZRN3 SON | 1.59e-09 | 1116 | 108 | 19 | 31753913 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ABCF1 WAPL LEO1 PARG ZMYM2 CBLC CHD4 ITPRID2 LATS1 TPX2 IQSEC1 PLA2G4A PACS2 TLN2 TOPORS SON | 2.36e-09 | 774 | 108 | 16 | 15302935 |
| Pubmed | NOL4 TTC28 DVL2 ZMYM2 ZDBF2 CHD4 JMJD1C PTPN13 DST UBR5 GCN1 GOLGB1 | 7.66e-09 | 418 | 108 | 12 | 34709266 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | ABCF1 RANBP3 DVL2 ZDBF2 JMJD1C TPX2 PLA2G4A USP15 GCN1 GOLGB1 | 8.06e-09 | 256 | 108 | 10 | 33397691 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOL4 ABCF1 LRCH2 RBM45 ZNF618 MRPS27 ZMYM2 CHD4 ARID1A GPC6 PTPN13 DST IQSEC1 DNM3 TAF15 GCN1 SON | 4.07e-08 | 1082 | 108 | 17 | 38697112 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ABCF1 WAPL LRCH2 GPATCH1 DVL2 CHD4 ARID1A ITPR3 UBR5 TPX2 USP15 | 1.35e-07 | 440 | 108 | 11 | 34244565 |
| Pubmed | 1.68e-07 | 268 | 108 | 9 | 33640491 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MIS18BP1 LEO1 TTC28 RBM33 ZMYM2 ZDBF2 ITPRID2 ARID1A UBR5 BSN TOPORS GOLGB1 | 3.12e-07 | 588 | 108 | 12 | 38580884 |
| Pubmed | 3.13e-07 | 209 | 108 | 8 | 36779422 | ||
| Pubmed | USP53 DR1 ABL2 RBM33 ZMYM2 ITPRID2 LATS1 DST CPLANE1 GCN1 GOLGB1 | 3.62e-07 | 486 | 108 | 11 | 20936779 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | USP53 ABCF1 MIS18BP1 ABL2 LRCH2 TTC28 GPATCH1 DVL2 NEDD1 LATS1 UBR5 CPLANE1 USP15 PDZRN3 | 4.25e-07 | 853 | 108 | 14 | 28718761 |
| Pubmed | WAPL TTC28 RANBP3 NSD1 ARID1A JMJD1C PTPN13 LATS1 TPX2 USP15 GCN1 | 1.19e-06 | 549 | 108 | 11 | 38280479 | |
| Pubmed | RANBP3 DVL2 ZDBF2 ITPR3 DST OSBPL2 UBR5 PLA2G4A USP15 GCN1 VPS13B | 1.66e-06 | 568 | 108 | 11 | 37774976 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 ABL2 TTC28 RANBP3 CCDC18 ITPRID2 PTPN13 LATS1 DST IQSEC1 RABGEF1 GOLGB1 DOP1A | 2.83e-06 | 861 | 108 | 13 | 36931259 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.53e-06 | 203 | 108 | 7 | 22083510 | |
| Pubmed | 6.92e-06 | 225 | 108 | 7 | 12168954 | ||
| Pubmed | 8.94e-06 | 234 | 108 | 7 | 36243803 | ||
| Pubmed | JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis. | 9.55e-06 | 2 | 108 | 2 | 30622285 | |
| Pubmed | Transgenic expression of Dspp partially rescued the long bone defects of Dmp1-null mice. | 9.55e-06 | 2 | 108 | 2 | 26686820 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21501587 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21420385 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17033625 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23349460 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9104811 | ||
| Pubmed | An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer. | 9.55e-06 | 2 | 108 | 2 | 24125968 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16051816 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29364865 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16679514 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24441185 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 36946317 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18275062 | ||
| Pubmed | Dentin sialoprotein and dentin phosphoprotein overexpression during amelogenesis. | 9.55e-06 | 2 | 108 | 2 | 16014627 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9421236 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31519864 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29588348 | ||
| Pubmed | Pathogenesis of Dugbe virus infection in wild-type and interferon-deficient mice. | 9.55e-06 | 2 | 108 | 2 | 16760403 | |
| Pubmed | Hindbrain rhombic lip is comprised of discrete progenitor cell populations allocated by Pax6. | 1.03e-05 | 14 | 108 | 3 | 16364898 | |
| Pubmed | 1.10e-05 | 446 | 108 | 9 | 24255178 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.18e-05 | 341 | 108 | 8 | 32971831 | |
| Pubmed | 1.43e-05 | 167 | 108 | 6 | 25659891 | ||
| Pubmed | 1.98e-05 | 105 | 108 | 5 | 23284306 | ||
| Pubmed | CTTNBP2 ZNF618 MRPS27 USP37 JMJD1C PPP1R26 SBF2 PDZRN3 DOP1A | 2.43e-05 | 493 | 108 | 9 | 15368895 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ABCF1 ABL2 LEO1 CHD4 PTPN12 LATS1 DST TPX2 DNM3 FGFR2 MAP3K13 CPLANE1 | 2.68e-05 | 910 | 108 | 12 | 36736316 |
| Pubmed | 2.84e-05 | 503 | 108 | 9 | 16964243 | ||
| Pubmed | A critical function for type I interferons in cancer immunoediting. | 2.86e-05 | 3 | 108 | 2 | 15951814 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 11149946 | ||
| Pubmed | Tissue factor binds to and inhibits interferon-α receptor 1 signaling. | 2.86e-05 | 3 | 108 | 2 | 38141610 | |
| Pubmed | Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. | 2.86e-05 | 3 | 108 | 2 | 10801979 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 39168127 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12438645 | ||
| Pubmed | Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. | 2.86e-05 | 3 | 108 | 2 | 22722203 | |
| Pubmed | PAX6 maintains β cell identity by repressing genes of alternative islet cell types. | 2.86e-05 | 3 | 108 | 2 | 27941241 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 10233935 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 14966118 | ||
| Pubmed | Temporal and spatial localization of the dentin matrix proteins during dentin biomineralization. | 2.86e-05 | 3 | 108 | 2 | 19001636 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 19549382 | ||
| Pubmed | Expression of SIBLINGs and their partner MMPs in salivary glands. | 2.86e-05 | 3 | 108 | 2 | 15329369 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 22992961 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12489180 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 33456576 | ||
| Pubmed | The RNase MCPIP3 promotes skin inflammation by orchestrating myeloid cytokine response. | 2.86e-05 | 3 | 108 | 2 | 34215755 | |
| Pubmed | A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice. | 2.86e-05 | 3 | 108 | 2 | 34757384 | |
| Pubmed | A Microbiota-Dependent Subset of Skin Macrophages Protects Against Cutaneous Bacterial Infection. | 2.86e-05 | 3 | 108 | 2 | 35757750 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 15879158 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 24105635 | ||
| Pubmed | Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). | 2.86e-05 | 3 | 108 | 2 | 15954904 | |
| Pubmed | Role of type I interferon receptor signaling on NK cell development and functions. | 2.86e-05 | 3 | 108 | 2 | 25333658 | |
| Pubmed | Role of PKR and Type I IFNs in viral control during primary and secondary infection. | 2.86e-05 | 3 | 108 | 2 | 20585572 | |
| Pubmed | Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes. | 2.86e-05 | 3 | 108 | 2 | 34348155 | |
| Pubmed | 2.97e-05 | 282 | 108 | 7 | 23667531 | ||
| Pubmed | 2.98e-05 | 506 | 108 | 9 | 30890647 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.03e-05 | 283 | 108 | 7 | 30585729 | |
| Pubmed | TTC28 GPATCH1 CHD4 GTPBP2 PTPN13 DST OSBPL2 UBR5 TAF15 GCN1 GOLGB1 | 3.12e-05 | 777 | 108 | 11 | 35844135 | |
| Pubmed | MAP9 CACNA2D1 IL16 ABCF1 CTTNBP2 LRCH2 ANK2 GRIA1 ARID1A DST IQSEC1 PACS2 TLN2 TAF15 BSN | 3.67e-05 | 1431 | 108 | 15 | 37142655 | |
| Pubmed | 3.78e-05 | 653 | 108 | 10 | 22586326 | ||
| Pubmed | MAP9 DR1 ANK2 LEO1 GRIA1 CHD4 ARID1A CHRNB3 LATS1 DST CFAP74 TAF15 BSN GOLGB1 DOP1A | 4.01e-05 | 1442 | 108 | 15 | 35575683 | |
| Pubmed | 4.17e-05 | 407 | 108 | 8 | 12693553 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WAPL RBM33 GPATCH1 NSD1 ZMYM2 ZDBF2 CHD4 ARID1A JMJD1C TPX2 TAF15 SON | 4.23e-05 | 954 | 108 | 12 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DR1 LEO1 GPATCH1 NSD1 ZMYM2 CHD4 ARID1A JMJD1C ITPR3 DST TPX2 TAF15 PAX6 SON | 4.87e-05 | 1294 | 108 | 14 | 30804502 |
| Pubmed | RAG2 NOL4 DSPP CYP24A1 ZMYM2 GRIA1 CHRNB3 TRIM36 PDZRN3 VPS13B | 5.70e-05 | 686 | 108 | 10 | 29987050 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 20056126 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 19620292 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 10982374 | ||
| Pubmed | Zika virus spreads through infection of lymph node-resident macrophages. | 5.71e-05 | 4 | 108 | 2 | 36795561 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 11559791 | ||
| Pubmed | Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth. | 5.71e-05 | 4 | 108 | 2 | 32780802 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 26310138 | ||
| Pubmed | GART, SON, IFNAR, and CRF2-4 genes cluster on human chromosome 21 and mouse chromosome 16. | 5.71e-05 | 4 | 108 | 2 | 8318737 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 14981113 | ||
| Pubmed | Visualizing the Selectivity and Dynamics of Interferon Signaling In Vivo. | 5.71e-05 | 4 | 108 | 2 | 31825834 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 25037176 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 26542066 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 23990781 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 33924850 | ||
| Pubmed | Investigation of osteocalcin, osteonectin, and dentin sialophosphoprotein in developing human teeth. | 5.71e-05 | 4 | 108 | 2 | 11856645 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 12960379 | ||
| Pubmed | FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development. | 5.71e-05 | 4 | 108 | 2 | 10821755 | |
| Interaction | PHLPP1 interactions | ABCF1 RANBP3 DVL2 ZDBF2 ARID1A JMJD1C TPX2 PLA2G4A USP15 GCN1 GOLGB1 PHLPP2 | 2.07e-07 | 333 | 107 | 12 | int:PHLPP1 |
| Interaction | PHF21A interactions | NOL4 TTC28 DVL2 ZMYM2 ZDBF2 JMJD1C PTPN13 DST UBR5 RABGEF1 PAX6 GOLGB1 | 2.84e-07 | 343 | 107 | 12 | int:PHF21A |
| Interaction | RNF43 interactions | MIS18BP1 TTC28 RBM33 DVL2 NEDD1 ARID1A JMJD1C PTPN13 UBR5 USP15 GCN1 VPS13B GOLGB1 | 4.31e-07 | 427 | 107 | 13 | int:RNF43 |
| Interaction | RCOR1 interactions | NOL4 TTC28 DVL2 ZMYM2 ZDBF2 CHD4 JMJD1C PTPN13 DST UBR5 RABGEF1 USP15 GCN1 | 2.19e-06 | 494 | 107 | 13 | int:RCOR1 |
| Interaction | NAA40 interactions | ABCF1 WAPL ANK2 RANBP3 GPATCH1 PARG DVL2 ZMYM2 CHD4 NEDD1 PTPN12 PTPN13 DST TPX2 TAF15 GCN1 GOLGB1 SON | 3.71e-06 | 978 | 107 | 18 | int:NAA40 |
| Interaction | NUP43 interactions | DR1 MIS18BP1 LEO1 GPATCH1 NSD1 ZMYM2 ZDBF2 ITPRID2 ARID1A JMJD1C HELB DST UBR5 SON | 5.62e-06 | 625 | 107 | 14 | int:NUP43 |
| Interaction | AR interactions | WAPL ABL2 RBM33 RANBP3 BCL7B NSD1 ZMYM2 CHD4 ITPRID2 ARID1A JMJD1C UBR5 TPX2 TAF15 PAX6 GCN1 SON | 1.80e-05 | 992 | 107 | 17 | int:AR |
| Interaction | SIRT6 interactions | ABCF1 WAPL LRCH2 FAT3 GPATCH1 DVL2 ZDBF2 CHD4 ARID1A ITPR3 UBR5 TPX2 USP15 | 2.85e-05 | 628 | 107 | 13 | int:SIRT6 |
| Interaction | KDM1A interactions | NOL4 IL16 LEO1 TTC28 DVL2 ZMYM2 ZDBF2 CHD4 JMJD1C GTPBP2 PTPN13 DST UBR5 USP15 GCN1 GOLGB1 | 3.60e-05 | 941 | 107 | 16 | int:KDM1A |
| Interaction | SAP18 interactions | 3.63e-05 | 305 | 107 | 9 | int:SAP18 | |
| Interaction | MECP2 interactions | NOL4 ABCF1 LRCH2 RBM45 ZNF618 MRPS27 NSD1 ZMYM2 CHD4 ARID1A GPC6 PTPN13 DST IQSEC1 DNM3 TAF15 GCN1 EIF2AK2 SON | 4.34e-05 | 1287 | 107 | 19 | int:MECP2 |
| Interaction | CDC5L interactions | RBM45 GPATCH1 ZDBF2 CHD4 ARID1A DST UBR5 TPX2 TLN2 TAF15 MAP3K13 GCN1 EIF2AK2 GOLGB1 SON | 4.54e-05 | 855 | 107 | 15 | int:CDC5L |
| Interaction | GOLGA1 interactions | 5.51e-05 | 183 | 107 | 7 | int:GOLGA1 | |
| Interaction | BICD1 interactions | 5.68e-05 | 250 | 107 | 8 | int:BICD1 | |
| Interaction | USP7 interactions | CACNA2D1 MYOT LRCH2 RBM45 FAT3 DVL2 NSD1 MARCHF7 ZDBF2 LEPR ZBBX IFNAR1 DST SCN3A TPX2 BSN USP15 VPS13B GOLGB1 | 5.69e-05 | 1313 | 107 | 19 | int:USP7 |
| Interaction | POU5F1 interactions | ABCF1 WAPL LEO1 ZMYM2 CHD4 ARID1A JMJD1C ITPR3 BRDT UBR5 USP15 GCN1 | 6.34e-05 | 584 | 107 | 12 | int:POU5F1 |
| Interaction | DYNLL2 interactions | 8.09e-05 | 263 | 107 | 8 | int:DYNLL2 | |
| Interaction | SCARB2 interactions | 8.22e-05 | 195 | 107 | 7 | int:SCARB2 | |
| Interaction | WWTR1 interactions | 8.39e-05 | 422 | 107 | 10 | int:WWTR1 | |
| Interaction | HNRNPU interactions | CACNA2D1 ABCF1 RBM45 MRPS27 CHD4 NEDD1 IFNAR1 GTPBP2 UBR5 SBF2 TPX2 TAF15 CPLANE1 USP15 GCN1 GOLGB1 | 1.11e-04 | 1035 | 107 | 16 | int:HNRNPU |
| Interaction | ZSWIM9 interactions | 1.12e-04 | 18 | 107 | 3 | int:ZSWIM9 | |
| Interaction | NINL interactions | USP53 ABCF1 MIS18BP1 TTC28 GPATCH1 MRPS27 NEDD1 PTPN13 LATS1 UBR5 | 1.64e-04 | 458 | 107 | 10 | int:NINL |
| Interaction | DSPP interactions | 1.66e-04 | 4 | 107 | 2 | int:DSPP | |
| Interaction | CCT8L2 interactions | 1.92e-04 | 157 | 107 | 6 | int:CCT8L2 | |
| Interaction | KCNA3 interactions | IL16 ABL2 ANK2 TTC28 DVL2 JMJD1C PTPN13 LATS1 DST TLN2 BSN GCN1 GOLGB1 DOP1A | 2.07e-04 | 871 | 107 | 14 | int:KCNA3 |
| Cytoband | 1p22.1 | 5.97e-05 | 32 | 108 | 3 | 1p22.1 | |
| Cytoband | 4q21.3 | 2.97e-04 | 11 | 108 | 2 | 4q21.3 | |
| GeneFamily | SIBLING family | 1.97e-04 | 5 | 81 | 2 | 1279 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.82e-04 | 161 | 81 | 5 | 593 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.50e-03 | 13 | 81 | 2 | 1186 | |
| GeneFamily | Immunoglobulin like domain containing | 1.75e-03 | 193 | 81 | 5 | 594 | |
| GeneFamily | Ubiquitin specific peptidases | 2.02e-03 | 56 | 81 | 3 | 366 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 2.90e-03 | 18 | 81 | 2 | 812 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 2.90e-03 | 18 | 81 | 2 | 620 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 4.32e-03 | 22 | 81 | 2 | 579 | |
| GeneFamily | PDZ domain containing | 4.84e-03 | 152 | 81 | 4 | 1220 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | WAPL TTC28 PARG ZMYM2 MARCHF7 MBOAT2 PTPN12 PTPN13 DST UBR5 TAF15 USP15 VPS13B SON PHLPP2 | 2.35e-06 | 856 | 108 | 15 | M4500 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 6.85e-06 | 404 | 108 | 10 | M19488 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | ZFAND3 ANK2 TTC28 NEDD1 ARID1A HELB PTPN12 OSBPL2 SBF2 TPX2 DNM3 FGFR2 USP15 PDZRN3 VPS13B | 1.68e-05 | 1009 | 108 | 15 | M157 |
| Coexpression | GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP | 1.75e-05 | 131 | 108 | 6 | M8922 | |
| Coexpression | GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP | 1.91e-05 | 199 | 108 | 7 | M5753 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP | 1.97e-05 | 200 | 108 | 7 | M6635 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 2.30e-05 | 465 | 108 | 10 | M39066 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL | 3.85e-05 | 304 | 108 | 8 | M45711 | |
| Coexpression | JAATINEN_HEMATOPOIETIC_STEM_CELL_UP | 5.90e-05 | 323 | 108 | 8 | M15107 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP | 1.13e-04 | 183 | 108 | 6 | M6670 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 1.25e-04 | 268 | 108 | 7 | M45696 | |
| Coexpression | WANG_CLIM2_TARGETS_UP | 1.31e-04 | 270 | 108 | 7 | M10334 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | WAPL ABL2 MARCHF7 JMJD1C GTPBP2 DST OSBPL2 PLA2G4A RABGEF1 TRIM36 TOPORS GOLGB1 | 1.48e-04 | 822 | 108 | 12 | M6782 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | NOL4 CTTNBP2 ANK2 GRIA1 PTPRT SCN3A DNM3 TLN2 BSN TRIM36 DOP1A | 1.56e-04 | 703 | 108 | 11 | M39070 |
| Coexpression | GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN | 1.69e-04 | 197 | 108 | 6 | M4540 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN | 1.74e-04 | 198 | 108 | 6 | M3352 | |
| Coexpression | GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP | 1.84e-04 | 200 | 108 | 6 | M6473 | |
| Coexpression | GSE19512_NAUTRAL_VS_INDUCED_TREG_DN | 1.84e-04 | 200 | 108 | 6 | M8359 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP | 1.84e-04 | 200 | 108 | 6 | M7294 | |
| Coexpression | GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP | 1.84e-04 | 200 | 108 | 6 | M4103 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | 1.84e-04 | 200 | 108 | 6 | M6789 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP | 2.06e-04 | 130 | 108 | 5 | M6590 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ABCF1 WAPL LEO1 PARG CCDC18 ZDBF2 USP37 PTPN12 UBR5 TPX2 TAF15 ZC3H12C PAX6 TOPORS | 3.26e-07 | 532 | 104 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 4.79e-07 | 194 | 104 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CACNA2D1 ABCF1 LEO1 FAT3 ZDBF2 LATS1 DST UBR5 TPX2 IQSEC1 TAF15 ZC3H12C PAX6 DOP1A PHLPP2 | 6.85e-07 | 654 | 104 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | CACNA2D1 CTTNBP2 FAT3 NSD1 GPC6 LATS1 DST SCN3A TLN2 DMP1 CPLANE1 GCN1 | 7.58e-07 | 408 | 104 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ABCF1 WAPL MIS18BP1 LRCH2 ANK2 LEO1 ZNF618 NSD1 ZMYM2 CBLC MARCHF7 ZDBF2 CHD4 ARID1A PTPN12 TPX2 CFAP74 TAF15 CPLANE1 TOPORS | 2.60e-06 | 1257 | 104 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.88e-06 | 328 | 104 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOL4 ABCF1 WAPL MIS18BP1 LRCH2 ANK2 LEO1 ZNF618 NSD1 ZMYM2 CBLC MARCHF7 ZDBF2 CHD4 ARID1A PTPN12 TPX2 CFAP74 TAF15 CPLANE1 TOPORS | 6.74e-06 | 1459 | 104 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.36e-05 | 369 | 104 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ABCF1 WAPL MIS18BP1 PARG CCDC18 DST TPX2 CFAP74 TAF15 TOPORS USP15 | 1.91e-05 | 469 | 104 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | CACNA2D1 TTC28 ZNF618 FAT3 GPC6 TAF15 CPLANE1 GCN1 VPS13B SON | 1.96e-05 | 385 | 104 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200 | 2.06e-05 | 170 | 104 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | USP53 ABCF1 MIS18BP1 ABL2 RBM45 ZNF618 CHD4 ARID1A GPC6 IFNAR1 PTPN12 BRDT CPLANE1 TOPORS | 3.86e-05 | 806 | 104 | 14 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CACNA2D1 ABCF1 RBM33 FAT3 ZMYM2 ZDBF2 IFNAR1 LATS1 UBR5 TPX2 TAF15 ZC3H12C PAX6 USP15 | 5.36e-05 | 831 | 104 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 7.67e-05 | 209 | 104 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | CACNA2D1 ABCF1 ANK2 LEO1 FAT3 CCDC18 ZDBF2 LATS1 UBR5 TPX2 DNM3 TAF15 ZC3H12C PAX6 DOP1A | 8.70e-05 | 983 | 104 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 9.30e-05 | 149 | 104 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CACNA2D1 ABCF1 FAT3 CCDC18 DVL2 ZMYM2 ZDBF2 LATS1 UBR5 TPX2 CFAP74 TAF15 ZC3H12C PAX6 USP15 | 9.31e-05 | 989 | 104 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.33e-05 | 291 | 104 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.42e-04 | 54 | 104 | 4 | gudmap_developingGonad_P2_ovary_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.47e-04 | 232 | 104 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.48e-04 | 311 | 104 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.51e-04 | 312 | 104 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | CACNA2D1 CTTNBP2 FAT3 NSD1 GPC6 LATS1 DST SCN3A TLN2 DMP1 CPLANE1 GCN1 VPS13B | 1.56e-04 | 806 | 104 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CACNA2D1 CTTNBP2 TTC28 FAT3 GPC6 GTPBP2 LATS1 DST SCN3A TLN2 CPLANE1 GCN1 EIF2AK2 | 1.56e-04 | 806 | 104 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.68e-04 | 105 | 104 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k5_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 1.76e-04 | 407 | 104 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CACNA2D1 ANK2 TTC28 ZNF618 FAT3 GRIA1 GPC6 SCN3A TAF15 CPLANE1 GCN1 VPS13B SON | 1.80e-04 | 818 | 104 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 2.08e-04 | 416 | 104 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CACNA2D1 MIS18BP1 ZNF618 FAT3 CCDC18 ZDBF2 GPC6 MBOAT2 IFNAR1 PTPN13 TPX2 PLA2G4A PDZRN3 | 2.10e-04 | 831 | 104 | 13 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_100 | 2.44e-04 | 62 | 104 | 4 | gudmap_kidney_P1_CapMes_Crym_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.65e-04 | 339 | 104 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.88e-04 | 259 | 104 | 7 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.92e-04 | 65 | 104 | 4 | gudmap_developingGonad_e12.5_epididymis_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.11e-04 | 186 | 104 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_200 | 3.12e-04 | 120 | 104 | 5 | gudmap_kidney_P1_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.28e-04 | 67 | 104 | 4 | gudmap_developingGonad_e12.5_testes_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#4_top-relative-expression-ranked_100 | 3.52e-04 | 6 | 104 | 2 | gudmap_developingKidney_e15.5_Peripheral blastema_100_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | IL16 WAPL MIS18BP1 LRCH2 ZNF618 NSD1 ZMYM2 MARCHF7 CHD4 ARID1A LEPR PTPN12 TPX2 TAF15 CPLANE1 PDZRN3 | 3.78e-04 | 1252 | 104 | 16 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | USP53 DR1 MIS18BP1 ABL2 RBM45 CCDC18 GPC6 JMJD1C IFNAR1 PTPN12 BRDT CPLANE1 | 4.15e-04 | 776 | 104 | 12 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_500 | 4.22e-04 | 276 | 104 | 7 | gudmap_kidney_P1_CapMes_Crym_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.82e-04 | 202 | 104 | 6 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.05e-04 | 75 | 104 | 4 | gudmap_developingGonad_e14.5_ ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200 | 5.05e-04 | 75 | 104 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_500 | 5.60e-04 | 33 | 104 | 3 | gudmap_developingGonad_P2_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | USP53 DR1 MIS18BP1 ABL2 RBM45 ZNF618 ARID1A GPC6 JMJD1C IFNAR1 CPLANE1 TOPORS | 5.68e-04 | 804 | 104 | 12 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_500 | 6.12e-04 | 34 | 104 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k5_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_200 | 6.12e-04 | 139 | 104 | 5 | gudmap_kidney_P2_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 6.14e-04 | 294 | 104 | 7 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | DR1 MIS18BP1 CTTNBP2 ABL2 RBM45 ZNF618 ARID1A GPC6 JMJD1C IFNAR1 PTPN12 CPLANE1 | 6.40e-04 | 815 | 104 | 12 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ABCF1 WAPL MIS18BP1 LRCH2 ANK2 ZNF618 FAT3 ZMYM2 ZDBF2 ARID1A TPX2 CFAP74 TAF15 ZC3H12C | 6.57e-04 | 1060 | 104 | 14 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | NOL4 MAP9 CACNA2D1 ANK2 FAT3 NSD1 GRIA1 LATS1 SCN3A DNM3 TAF15 CPLANE1 | 6.61e-04 | 818 | 104 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.67e-04 | 35 | 104 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k5 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 7.42e-04 | 83 | 104 | 4 | GSM538348_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 7.65e-04 | 498 | 104 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_100 | 7.76e-04 | 84 | 104 | 4 | gudmap_kidney_P2_CapMes_Crym_100 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 8.11e-04 | 85 | 104 | 4 | GSM791143_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | DR1 ABCF1 ABL2 RBM45 ZNF618 DVL2 ARID1A GPC6 IFNAR1 FGFR2 EIF2AK2 SON | 8.60e-04 | 843 | 104 | 12 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_100 | 8.85e-04 | 87 | 104 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_500 | 9.18e-04 | 39 | 104 | 3 | gudmap_developingGonad_e12.5_ovary_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_100 | 9.63e-04 | 89 | 104 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.00e-03 | 90 | 104 | 4 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 1.32e-03 | 165 | 104 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.33e-03 | 97 | 104 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CACNA2D1 ZNF618 FAT3 CCDC18 ZDBF2 VSIG10 GPC6 TMC3 MBOAT2 TPX2 PLA2G4A | 1.35e-03 | 768 | 104 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 1.38e-03 | 98 | 104 | 4 | gudmap_kidney_P2_CapMes_Crym_k3_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 1.39e-03 | 45 | 104 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 9.64e-10 | 190 | 108 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.11e-09 | 193 | 108 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-09 | 196 | 108 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.74e-08 | 185 | 108 | 8 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.23e-08 | 191 | 108 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-08 | 192 | 108 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.42e-08 | 193 | 108 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.42e-08 | 193 | 108 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.52e-08 | 194 | 108 | 8 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.52e-08 | 194 | 108 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.62e-08 | 195 | 108 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-08 | 195 | 108 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.73e-08 | 196 | 108 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.95e-08 | 198 | 108 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.75e-07 | 187 | 108 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 3.88e-07 | 188 | 108 | 7 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-07 | 188 | 108 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-07 | 192 | 108 | 7 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.64e-07 | 193 | 108 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-07 | 195 | 108 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.89e-07 | 200 | 108 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.67e-06 | 177 | 108 | 6 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.99e-06 | 179 | 108 | 6 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.31e-06 | 181 | 108 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.66e-06 | 183 | 108 | 6 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.84e-06 | 184 | 108 | 6 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 6.40e-06 | 187 | 108 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.40e-06 | 187 | 108 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-06 | 188 | 108 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-06 | 188 | 108 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-06 | 188 | 108 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.81e-06 | 189 | 108 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.01e-06 | 190 | 108 | 6 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-06 | 192 | 108 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-06 | 193 | 108 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-06 | 193 | 108 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 194 | 108 | 6 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 7.90e-06 | 194 | 108 | 6 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 194 | 108 | 6 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.14e-06 | 195 | 108 | 6 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 8.14e-06 | 195 | 108 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.14e-06 | 195 | 108 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.38e-06 | 196 | 108 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.38e-06 | 196 | 108 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | mild_COVID-19_(asymptomatic)|World / disease group, cell group and cell class (v2) | 8.38e-06 | 196 | 108 | 6 | 8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.38e-06 | 196 | 108 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-06 | 197 | 108 | 6 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.62e-06 | 197 | 108 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-06 | 197 | 108 | 6 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.62e-06 | 197 | 108 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 8.62e-06 | 197 | 108 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.87e-06 | 198 | 108 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.87e-06 | 198 | 108 | 6 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 8.87e-06 | 198 | 108 | 6 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.87e-06 | 198 | 108 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.87e-06 | 198 | 108 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 9.13e-06 | 199 | 108 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.13e-06 | 199 | 108 | 6 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.13e-06 | 199 | 108 | 6 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.13e-06 | 199 | 108 | 6 | 91882af9dc7265c9b419f4415cbcf656087a2ab3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.40e-06 | 200 | 108 | 6 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3---L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | 9c89e91bb630cc306a820927a36ea6fb3d13e9d7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.40e-06 | 200 | 108 | 6 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | 8821574d17b55dfea3ca0204e6b4c0ca6b19588a | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | 96b1d2e70fbbba744fd4356a70efcf356aca9abc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.40e-06 | 200 | 108 | 6 | ad6f1d4d7f5d7bab2ba2e4fff58c535290065c0e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-05 | 151 | 108 | 5 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-05 | 155 | 108 | 5 | 498e52e2364ff44d3c0c707ba22468217031f5bd | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.59e-05 | 168 | 108 | 5 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.59e-05 | 168 | 108 | 5 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-05 | 171 | 108 | 5 | 05014cf6746e6663e376fdd681f1b43a7081c603 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-05 | 171 | 108 | 5 | d6114db2292fbb27b39d090d51fd305a135b1ccf | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.42e-05 | 173 | 108 | 5 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.60e-05 | 174 | 108 | 5 | 9f114e61458659005b6d0b4aa30a7a059e7aa5c6 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.60e-05 | 174 | 108 | 5 | 7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.78e-05 | 175 | 108 | 5 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 6.78e-05 | 175 | 108 | 5 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 6.78e-05 | 175 | 108 | 5 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.96e-05 | 176 | 108 | 5 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 176 | 108 | 5 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.15e-05 | 177 | 108 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.35e-05 | 178 | 108 | 5 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 7.54e-05 | 179 | 108 | 5 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.54e-05 | 179 | 108 | 5 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.74e-05 | 180 | 108 | 5 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 8.16e-05 | 182 | 108 | 5 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | 398ce074a04f6482470b488f1affae4af7d2ec58 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 184 | 108 | 5 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 184 | 108 | 5 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 184 | 108 | 5 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 9.04e-05 | 186 | 108 | 5 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| Drug | AC1L9LJU | 3.87e-06 | 137 | 107 | 7 | CID000448056 | |
| Drug | Flurbiprofen [5104-49-4]; Up 200; 16.4uM; HL60; HT_HG-U133A | 4.60e-06 | 199 | 107 | 8 | 3095_UP | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 4.60e-06 | 199 | 107 | 8 | 6188_UP | |
| Disease | lung adenocarcinoma (is_implicated_in) | 9.15e-07 | 49 | 106 | 5 | DOID:3910 (is_implicated_in) | |
| Disease | Intellectual Disability | 3.48e-05 | 447 | 106 | 9 | C3714756 | |
| Disease | Autistic Disorder | 4.52e-05 | 261 | 106 | 7 | C0004352 | |
| Disease | autistic disorder (implicated_via_orthology) | 7.63e-05 | 4 | 106 | 2 | DOID:12849 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 7.77e-05 | 121 | 106 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | pelvic organ prolapse | 1.35e-04 | 136 | 106 | 5 | EFO_0004710 | |
| Disease | smoking cessation | 1.77e-04 | 325 | 106 | 7 | EFO_0004319 | |
| Disease | breast cancer (is_implicated_in) | 2.13e-04 | 150 | 106 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 2.71e-04 | 35 | 106 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | colon cancer (is_implicated_in) | 2.95e-04 | 36 | 106 | 3 | DOID:219 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 3.13e-04 | 163 | 106 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | C-C motif chemokine 5 measurement | 3.53e-04 | 8 | 106 | 2 | EFO_0008053 | |
| Disease | rectum cancer (is_implicated_in) | 4.53e-04 | 9 | 106 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | Adenoid Cystic Carcinoma | 4.73e-04 | 100 | 106 | 4 | C0010606 | |
| Disease | Odontome | 5.65e-04 | 10 | 106 | 2 | C0524730 | |
| Disease | neuroblastoma (is_implicated_in) | 5.65e-04 | 10 | 106 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Tooth Abnormalities | 5.65e-04 | 10 | 106 | 2 | C0040427 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 5.73e-04 | 45 | 106 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | Malignant neoplasm of stomach | 7.65e-04 | 300 | 106 | 6 | C0024623 | |
| Disease | esophagus adenocarcinoma (is_marker_for) | 8.24e-04 | 12 | 106 | 2 | DOID:4914 (is_marker_for) | |
| Disease | lymphocyte measurement | 8.54e-04 | 117 | 106 | 4 | EFO_0803546 | |
| Disease | Endometrial Neoplasms | 1.20e-03 | 58 | 106 | 3 | C0014170 | |
| Disease | mitochondrial DNA measurement | 1.21e-03 | 328 | 106 | 6 | EFO_0006312 | |
| Disease | red blood cell density measurement | 1.28e-03 | 880 | 106 | 10 | EFO_0007978 | |
| Disease | liver volume | 1.30e-03 | 15 | 106 | 2 | EFO_0600048 | |
| Disease | urate measurement | 1.45e-03 | 895 | 106 | 10 | EFO_0004531 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 1.48e-03 | 16 | 106 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | arterial stiffness measurement | 1.60e-03 | 64 | 106 | 3 | EFO_0004517 | |
| Disease | Profound Mental Retardation | 1.62e-03 | 139 | 106 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.62e-03 | 139 | 106 | 4 | C0025363 | |
| Disease | Mental deficiency | 1.62e-03 | 139 | 106 | 4 | C0917816 | |
| Disease | Malignant neoplasm of breast | CTU2 ANK2 CYP24A1 ARID1A LEPR PLA2G4A FGFR2 MAP3K13 VPS13B GOLGB1 DOP1A | 1.68e-03 | 1074 | 106 | 11 | C0006142 |
| Disease | Inborn Errors of Metabolism | 1.68e-03 | 17 | 106 | 2 | C0025521 | |
| Disease | Benign neoplasm of stomach | 1.68e-03 | 17 | 106 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.68e-03 | 17 | 106 | 2 | C0496905 | |
| Disease | Renal Insufficiency | 1.68e-03 | 17 | 106 | 2 | C1565489 | |
| Disease | Carcinoma in situ of stomach | 1.68e-03 | 17 | 106 | 2 | C0154060 | |
| Disease | hyperglycemia (implicated_via_orthology) | 1.68e-03 | 17 | 106 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | Limb Deformities, Congenital | 1.68e-03 | 17 | 106 | 2 | C0206762 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.83e-03 | 67 | 106 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | borna disease (biomarker_via_orthology) | 1.88e-03 | 18 | 106 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | Endometrial Carcinoma | 2.24e-03 | 72 | 106 | 3 | C0476089 | |
| Disease | alpha-tocopherol measurement | 2.33e-03 | 20 | 106 | 2 | EFO_0007898 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.52e-03 | 157 | 106 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | Stomach Carcinoma | 2.57e-03 | 21 | 106 | 2 | C0699791 | |
| Disease | prothrombin time measurement | 2.57e-03 | 21 | 106 | 2 | EFO_0008390 | |
| Disease | serum IgM measurement | 2.82e-03 | 22 | 106 | 2 | EFO_0004993 | |
| Disease | portal hypertension (biomarker_via_orthology) | 2.82e-03 | 22 | 106 | 2 | DOID:10762 (biomarker_via_orthology) | |
| Disease | Kidney Failure | 2.82e-03 | 22 | 106 | 2 | C0035078 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.28e-03 | 169 | 106 | 4 | DOID:3908 (is_marker_for) | |
| Disease | Breast Carcinoma | 3.33e-03 | 538 | 106 | 7 | C0678222 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.35e-03 | 24 | 106 | 2 | C0345905 | |
| Disease | Brugada Syndrome (disorder) | 3.35e-03 | 24 | 106 | 2 | C1142166 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.35e-03 | 24 | 106 | 2 | C3805278 | |
| Disease | susceptibility to childhood ear infection measurement | 3.42e-03 | 171 | 106 | 4 | EFO_0007904 | |
| Disease | Leukemia, Myelocytic, Acute | 3.56e-03 | 173 | 106 | 4 | C0023467 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSATTGFNSIAENED | 16 | Q05901 | |
| AANAAENDFSVSQAE | 276 | Q8NE71 | |
| GQATAEDSGNSSDQE | 406 | Q9ULV8 | |
| NIEGAQDATENSASS | 591 | P42684 | |
| NTNEASSEGNSSDDS | 401 | Q58F21 | |
| SEDDAVTAAQQFAQS | 351 | Q9BX10 | |
| NFSEDEFDNGSTLQS | 1566 | Q5JWR5 | |
| NSSDESNGNDDANSE | 466 | Q9NZW4 | |
| EFQDENSNQSSVSDV | 86 | Q9BQE9 | |
| LNDNDGSSGASDQDT | 521 | O14641 | |
| SSDANRENAAAESGS | 341 | Q9H6Z4 | |
| AEDDTNEEQTTFTNS | 351 | P55895 | |
| SESDNSDNNTIFVQG | 226 | Q92804 | |
| FELSDNTNDQSGEQE | 101 | Q96EV2 | |
| ESTRNDESSEQENNG | 576 | Q9UPQ7 | |
| GEQQSEFSSFDKNDS | 226 | Q8IUH3 | |
| NFISGDISDTQASNE | 536 | Q96L73 | |
| EEAFASSQSSQGAQS | 66 | Q9UJ41 | |
| QDEQGSKVSDFFDQS | 2161 | Q14573 | |
| QELSQDSFGSQASSA | 601 | O14497 | |
| GIQDAFNDGSDSTFQ | 1186 | O14497 | |
| ENGANQSTATEDGFT | 151 | Q01484 | |
| NTNSISSNGEDSDEA | 186 | P26367 | |
| DTDGAEDFVSENSNN | 136 | P21802 | |
| SAGNRTANSEDSDEQ | 281 | P43627 | |
| SDSGSDSDSDQENAA | 21 | Q8WVC0 | |
| DSDSDQENAASGSNA | 26 | Q8WVC0 | |
| ESVDSADEQFQNTNA | 271 | Q6P0N0 | |
| LGDFSDTSADENSVN | 56 | Q49MG5 | |
| ETDSGKNQDFSSFDD | 386 | Q8NHV4 | |
| FDEGENSLGQNSFST | 486 | Q6ZWT7 | |
| YINSQGSEQQSDEDD | 1101 | O95835 | |
| GSEQQSDEDDQNTGS | 1106 | O95835 | |
| SGFEDSENTDIANSV | 801 | Q86WG5 | |
| DQQNNTGTDTDSDDD | 2386 | Q03001 | |
| SESDYSDGDNDSINS | 461 | Q6DN90 | |
| SDGDNDSINSTSNSN | 466 | Q6DN90 | |
| NVSDFSESSDSENSN | 371 | Q15652 | |
| QQDTAESSDDFGSQL | 796 | Q9UPA5 | |
| DANFTVQDNRDGSAS | 561 | Q86UP0 | |
| SVAENDENGQAENFS | 636 | Q9UQ16 | |
| SEDDQAGSGEANFQS | 776 | Q9BRR8 | |
| AGSGEANFQSSQDTD | 781 | Q9BRR8 | |
| ANFQSSQDTDLGETS | 786 | Q9BRR8 | |
| TSQDSGNYSNEDESE | 531 | P17181 | |
| FDEQEDGSSSQTANK | 326 | Q86W56 | |
| SEGAFSENNAENESG | 171 | P31269 | |
| SSSNEDSAANGSAET | 1026 | Q14005 | |
| SDQFNSVNFSEAEGT | 956 | P48357 | |
| ETASEDDNFGTAQSN | 1856 | Q92616 | |
| FSSEQEASDDAVQGQ | 206 | Q86VP3 | |
| ESGENSEQANTQDSG | 241 | Q13316 | |
| SDRISDEANSNFNQG | 376 | P28290 | |
| ASASASNQAGSSQDE | 156 | Q01658 | |
| SSDSFNEDNTAFAKQ | 101 | A8K0S8 | |
| NDEGFSSSSQDVNGF | 816 | O14522 | |
| ENFSVSDGEEGNTSD | 851 | O43283 | |
| ETESGNENSGYNSDE | 331 | Q9NSI5 | |
| NDVNFQDTSDESSGS | 481 | Q9Y625 | |
| VLGSSEDNFEDSSQF | 421 | Q07973 | |
| QDSNNSVDSSASDSD | 381 | Q9H799 | |
| GDFSADTSEINSNSD | 206 | P19525 | |
| EADSSENNDFNTLSG | 1411 | Q5T9S5 | |
| DDFVNVASFNSNAQD | 286 | P54289 | |
| GNSFNEEESESSVFD | 871 | Q8WZ74 | |
| VQSLSSFQSDSGDDN | 4336 | Q8TDW7 | |
| SESDSENFNQESEGR | 366 | Q9H992 | |
| SQDFTDGSNTEDSNL | 336 | Q5T9C2 | |
| EEGRDQTTSDQSNEF | 571 | P42261 | |
| QDDQSDNQSDYSVAS | 1356 | Q14839 | |
| VTATDADDANYGNSA | 181 | Q9ULB4 | |
| QGAEDTQNGTNFTSD | 181 | A6NLW8 | |
| SAGNRTANSEDSDEQ | 281 | P43626 | |
| ADTTEDQSGQTFDQS | 411 | P20648 | |
| FSEQQLEGTESSQAD | 691 | Q9C0B2 | |
| DVDAADSATAFGAQT | 396 | Q2VPK5 | |
| QNNDLDASSEDFSGT | 801 | Q8NG08 | |
| KSSSGNENDEQDSDN | 571 | Q5VUJ6 | |
| SGSVSFTDENISNQD | 61 | Q12923 | |
| GTENEDAGSDYQSDN | 446 | P47712 | |
| ASEEQSQNDEDNQGS | 296 | Q92552 | |
| DSFNDVGSDNSNQSS | 66 | Q9NQ86 | |
| NLDDSFSADETGDSN | 31 | Q7Z5M5 | |
| EDEVNSSFTSGRNNT | 456 | P12259 | |
| ITGFTDQATQDESAA | 121 | Q7Z4P5 | |
| DQATQDESAAETGQS | 126 | Q7Z4P5 | |
| SDSDERNSDGAVTQN | 606 | Q05209 | |
| QEQDALGSDASDFSD | 1181 | Q5T8A7 | |
| SFSSDNLAATDDDNE | 986 | Q9NY46 | |
| QDDDSAAESFNGNET | 256 | O94818 | |
| SDNSSGEFSEANQKV | 16 | Q9H1P3 | |
| EQSFDQDESGNRTSV | 96 | P32856 | |
| SSSTNDFQANSGAID | 1001 | Q70EK8 | |
| DTEATSGEGASQSNN | 171 | Q5T7W0 | |
| ATFSSNQSDNGLDSD | 1136 | Q6ZVD8 | |
| ESSDSNDSFQAAADE | 1366 | Q9HCK1 | |
| ENSQSEDSVGGDNDS | 676 | Q9Y4E8 | |
| SQSGTNNAENLDFTE | 501 | Q7Z5K2 | |
| NTLGQASASADFDAQ | 1071 | Q9BZZ2 | |
| SNKFQNSSVEDDDDV | 46 | Q9UBW7 | |
| GENTVENSSDFQASS | 1266 | Q96AY4 | |
| NSFVDALGSDEDSGN | 846 | Q86T82 | |
| QEQEQSYSSGDSDVS | 516 | Q9NS56 | |
| NSSQNGADDQSSASE | 2431 | Q7Z7G8 | |
| TAGTLNAENSETFAD | 2001 | Q9Y4G6 | |
| NGFQDLQDDSSEEQS | 516 | Q8N0Z9 | |
| SEENASSGDSEENTN | 81 | Q9C0D7 | |
| DFSFDQSERQSQDSS | 191 | Q6XPR3 | |
| QSDLFSEETTSDNNN | 56 | Q9H8U3 | |
| NGEENKDDDNVFSSN | 2201 | P18583 | |
| GSFDEEASAQSFQEV | 251 | A8MT70 | |
| ISFTSFNDESGENAE | 2691 | O95071 | |
| DQGANFSEVSNTSFE | 186 | Q7Z7D3 | |
| FINFSSLDDEGDTQN | 16 | Q9ULW0 | |
| NADNNSSAFTALSEE | 731 | Q14789 | |
| AAVFQAQDDSGAQDS | 196 | Q9UBF9 |